An increased risk of histoplasmosis has also been reported in patients who are immunosuppressed after receiving a solid organ transplant and in patients who have been prescribed an agent to inhibit the activity of tumor necrosis factor (TNF), which is essential in the response to infection with H. capsulatum [7,8,9,10,11,12,13]. Here, TNF is linked to histoplasmosis.